Stocks and Investing Stocks and Investing
Thu, July 29, 2021
Wed, July 28, 2021

Matt Miksic Maintained (BSX) at Buy with Increased Target to $52 on, Jul 28th, 2021


Published on 2024-10-27 17:22:23 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Boston Scientific Corporation" (BSX) at Buy with Increased Target from $50 to $52 on, Jul 28th, 2021.

Matt has made no other calls on BSX in the last 4 months.



There are 2 other peers that have a rating on BSX. Out of the 2 peers that are also analyzing BSX, 1 agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mike Matson of "Needham" Downgraded from Strong Buy to Hold on, Wednesday, May 26th, 2021


This is the rating of the analyst that currently disagrees with Matt


  • Travis Steed of "Barclays" Initiated at Buy and Held Target at $51 on, Tuesday, May 25th, 2021
Contributing Sources